D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Microsoft
MSFT
|
+$549M |
| 2 |
Tesla
TSLA
|
+$538M |
| 3 |
Pinduoduo
PDD
|
+$357M |
| 4 |
Intel
INTC
|
+$261M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$255M |
Top Sells
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$398M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$300M |
| 3 |
Procter & Gamble
PG
|
+$281M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$267M |
| 5 |
JPMorgan Chase
JPM
|
+$250M |
Sector Composition
| 1 | Technology | 20.4% |
| 2 | Healthcare | 13.71% |
| 3 | Financials | 11.95% |
| 4 | Consumer Discretionary | 11.45% |
| 5 | Industrials | 7.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Xencor
XNCR
$615M
| $487K | ﹤0.01% |
18,710
-7,264
| -28% | -$189K |
|
2577
Erasca
ERAS
$454M
| $487K | ﹤0.01% |
112,984
+96,148
| +571% | +$414K |
|
|
DX
2578
Dynex Capital
DX
$1.6B
| $485K | ﹤0.01% |
+38,105
| New | +$485K |
|
2579
Woodward
WWD
$14.4B
| $484K | ﹤0.01% |
5,012
| – | – |
|
2580
Athira Pharma
ATHA
$15.1M
| $482K | ﹤0.01% |
152,144
+24,022
| +19% | +$76.2K |
|
2581
LXP Industrial Trust
LXP
$2.71B
| $482K | ﹤0.01% |
48,116
-22,560
| -32% | -$226K |
|
2582
Realty Income
O
$54.8B
| $479K | ﹤0.01% |
+7,549
| New | +$479K |
|
2583
John B. Sanfilippo & Son
JBSS
$737M
| $478K | ﹤0.01% |
5,881
+2,773
| +89% | +$226K |
|
2584
Oxford Industries
OXM
$695M
| $477K | ﹤0.01% |
+5,124
| New | +$477K |
|
|
CLLS
2585
Cellectis
CLLS
$317M
| $477K | ﹤0.01% |
227,112
-51,215
| -18% | -$108K |
|
|
VLD
2586
DELISTED
Velo3D, Inc.
VLD
| $477K | ﹤0.01% |
+7,608
| New | +$477K |
|
2587
E.W. Scripps
SSP
$248M
| $476K | ﹤0.01% |
36,125
-17,767
| -33% | -$234K |
|
|
ACRE
2588
Ares Commercial Real Estate
ACRE
$266M
| $476K | ﹤0.01% |
46,270
+22,449
| +94% | +$231K |
|
2589
American Vanguard Corp
AVD
$158M
| $475K | ﹤0.01% |
21,883
-3,363
| -13% | -$73K |
|
2590
CubeSmart
CUBE
$9.31B
| $474K | ﹤0.01% |
11,783
-243,003
| -95% | -$9.78M |
|
2591
Advantage Solutions
ADV
$639M
| $472K | ﹤0.01% |
226,939
+110,983
| +96% | +$231K |
|
2592
TriCo Bancshares
TCBK
$1.47B
| $469K | ﹤0.01% |
+9,206
| New | +$469K |
|
2593
NBT Bancorp
NBTB
$2.24B
| $468K | ﹤0.01% |
10,779
-2,149
| -17% | -$93.3K |
|
2594
Omega Healthcare
OHI
$12.6B
| $462K | ﹤0.01% |
16,547
-10,665
| -39% | -$298K |
|
|
ORC
2595
Orchid Island Capital
ORC
$1.04B
| $462K | ﹤0.01% |
+44,037
| New | +$462K |
|
2596
Zegna
ZGN
$2.39B
| $461K | ﹤0.01% |
44,046
-25,905
| -37% | -$271K |
|
|
ROVR
2597
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $461K | ﹤0.01% |
+125,656
| New | +$461K |
|
2598
Stock Yards Bancorp
SYBT
$2.24B
| $460K | ﹤0.01% |
7,086
-1,510
| -18% | -$98.1K |
|
|
DALS
2599
DELISTED
DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
| $460K | ﹤0.01% |
45,992
| – | – |
|
2600
Aurinia Pharmaceuticals
AUPH
$1.65B
| $459K | ﹤0.01% |
106,284
+6,447
| +6% | +$27.9K |
|